International Journal of Drug Discovery and Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100007 - 100007
Published: April 9, 2025
Review
Exploring
Fungi
Within
the
Human
Gut
Microbiota:
Obstacles,
Innovations,
Therapeutic
Applications
and
Prospects
Ahead
Peng
Xue
1,†,
Chao
Luo
2,†,
Jiashu
Li
3,
Liang
Yang
3,*
Yuanyuan
Ma
1,*
1
Nantong
Key
Laboratory
of
Environmental
Toxicology,
Department
Occupational
Medicine
School
Public
Health,
University,
226019,
China
2
The
People’s
Hospital
Rugao,
Affiliated
Rugao
Xinglin
College,
226500,
3
Medicine,
Southern
University
Science
Technology,
Shenzhen
518055,
*
Correspondence:
[email protected]
(L.Y.);
[email protected]
(Y.M.)
Received:
15
September
2024;
Revised:
23
October
Accepted:
Published:
9
April
2025
Abstract:
in
human
gut
microbiota
participate
maintenance
health
regulation
physiological
processes.
This
review
examines
complex
role
fungi,
highlighting
challenges
such
as
diverse
fungal
populations,
cultivation
difficulties,
knowledge
gaps
their
functional
roles.
Recent
advancements
metagenomics
metabolomics
have
enabled
innovative
investigations
into
communities,
revealing
influence
on
host
metabolism
immune
responses.
Future
research
should
address
existing
explore
therapeutic
applications
fungi.
Interdisciplinary
collaborations
new
methodologies
are
proposed
to
enhance
current
understanding
fungi-host
interactions,
ultimately
improving
outcomes
guide
development
novel
treatment
strategies.
emphasizes
need
integrate
microbiome
studies
provide
a
comprehensive
health.
Gut Microbes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Sept. 16, 2024
Short-chain
fatty
acids
(SCFAs)
-
acetate,
propionate,
and
butyrate
are
important
bacterial
fermentation
metabolites
regulating
many
aspects
of
human
physiology.
Decreases
in
the
concentrations
any
or
multiple
SCFAs
associated
with
various
detrimental
effects
to
host.
Previous
research
has
broadly
focused
on
gut
microbiome
produced
as
a
group,
minimal
distinction
between
independently,
each
significantly
different
host
effects.
In
this
review,
we
comprehensively
delineate
roles
these
emphasis
receptor
affinity,
signaling
pathway
involvement,
net
physiologic
Butyrate
is
highlighted
due
its
unique
role
gastrointestinal-associated
functions,
especially
maintaining
barrier
integrity.
functions
by
promoting
epithelial
tight
junctions,
serving
fuel
for
colonocyte
ATP
production,
modulating
immune
system.
Interaction
system
occurs
locally
gastrointestinal
tract
systemically
brain.
Investigation
into
conducted
production
pathways
specific
players
involved
highlights
risk
use
gram-positive
targeted
antibiotics.
We
review
discuss
evidence
showing
relationship
butyrate-producing
genus,
Gut Microbes,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Feb. 16, 2025
The
gut
microbiota-derived
metabolite
indole-3-propionic
acid
(IPA)
plays
an
important
role
in
maintaining
intestinal
mucosal
homeostasis,
while
the
molecular
mechanisms
underlying
IPA
regulation
on
CD4+
T
cell
functions
inflammatory
bowel
disease
(IBD)
remain
elusive.
Here
we
investigated
roles
of
modulating
cells
and
its
therapeutic
potential
treatment
human
IBD.
Leveraging
metabolomics
microbial
community
analyses,
observed
that
levels
IPA-producing
microbiota
(e.g.
Peptostreptococcus,
Clostridium,
Fournierella)
were
decreased,
IPA-consuming
Parabacteroides,
Erysipelatoclostridium,
Lachnoclostridium)
increased
feces
IBD
patients
than
those
healthy
donors.
Dextran
sulfate
sodium
(DSS)-induced
acute
colitis
CD45RBhighCD4+
transfer-induced
chronic
models
then
established
mice
treated
orally
with
to
study
inflammation
vivo.
We
found
oral
administration
attenuated
both
mice,
as
characterized
by
body
weight,
reduced
pro-inflammatory
cytokines
TNF-α,
IFN-γ,
IL-17A)
histological
scores
colon.
further
utilized
RNA
sequencing,
docking
simulations,
surface
plasmon
resonance
analyses
identified
exerts
biological
effects
interacting
heat
shock
protein
70
(HSP70),
leading
inducing
Th1/Th17
apoptosis.
Consistently,
ectopic
expression
HSP70
conferred
resistance
IPA-induced
Therefore,
these
findings
identify
a
previously
unrecognized
pathway
which
modulates
provide
promising
avenue
for
Animals,
Journal Year:
2025,
Volume and Issue:
15(5), P. 710 - 710
Published: March 1, 2025
Intestinal
fungi,
collectively
referred
to
as
mycobiota,
constitute
a
small
(0.01-2%)
but
crucial
component
of
the
overall
intestinal
microbiota.
While
fungi
are
far
less
abundant
than
bacteria
in
gut,
volume
an
average
fungal
cell
is
roughly
100-fold
greater
that
bacterial
cell.
They
play
vital
role
nutrient
metabolism
and
maintaining
health.
The
composition
spatial
organization
mycobiota
vary
across
different
animal
species
influenced
by
multitude
factors,
including
age,
diet,
host's
physiological
state.
At
present,
quantitative
research
on
monogastric
animals
remains
scarce,
investigations
into
mechanisms
underlying
their
metabolic
functions
also
relatively
restricted.
This
review
delves
distribution
characteristics
Candida
albicans,
Saccharomyces
cerevisiae,
Kazachstania
slooffiae,
animals,
factors
influencing
composition,
consequent
impacts
host
objective
offer
insights
for
deeper
understanding
nutritional
significance
explore
which
they
affect
health
relation
inflammatory
bowel
disease
(IBD),
diarrhea,
obesity.
Through
systematic
evaluation
functional
contributions,
this
shifts
our
perception
from
overlooked
commensals
key
components
gut
ecosystem
dynamics,
emphasizing
potential
personalized
control
regulation
enhancement
prevention
treatment
strategies.
Microbiome,
Journal Year:
2025,
Volume and Issue:
13(1)
Published: March 7, 2025
The
mycobiome,
representing
the
fungal
component
of
microbial
communities,
is
increasingly
acknowledged
as
an
integral
part
gut
microbiome.
However,
research
in
this
area
remains
relatively
limited.
characterization
mycobiome
taxa
from
metagenomic
data
heavily
reliant
on
quality
software
and
databases.
In
study,
we
evaluated
feasibility
profiling
using
existing
bioinformatics
tools
simulated
data.
We
identified
seven
claiming
to
perform
taxonomic
assignment
shotgun
sequences.
One
these
was
outdated
required
substantial
modifications
code
be
functional
thus
excluded.
To
evaluate
accuracy
identification
relative
abundance
remaining
(Kraken2,
MetaPhlAn4,
EukDetect,
FunOMIC,
MiCoP,
HumanMycobiomeScan),
constructed
18
mock
communities
varying
species
richness
levels.
comprised
up
165
belonging
phyla
Ascomycota
Basidiomycota,
commonly
found
microbiomes.
Of
tools,
FunOMIC
HumanMycobiomeScan
needed
source
run.
Notably,
only
one
species,
Candida
orthopsilosis,
consistently
by
all
across
where
it
included.
Increasing
community
improved
precision
Kraken2
genus,
family
MetaPhlAn4
accurately
genera
present
most
species.
top
three
for
overall
both
estimation
were
respectively.
Adding
90%
99%
bacterial
background
did
not
significantly
impact
tools'
performance.
Among
whole
genome
reference
HMS,
MiCoP),
MiCoP
exhibited
highest
when
same
database
used.
Our
survey
mycobiome-specific
revealed
a
very
limited
selection
such
their
poor
robustness
due
error-prone
software,
along
with
significant
lack
comprehensive
databases
enabling
mycobiome.
None
implemented
fully
agreed
profiles.
recognized
but
EukDetect
provided
predictions
that
closest
correct
compositions.
Cell Host & Microbe,
Journal Year:
2024,
Volume and Issue:
32(10), P. 1668 - 1680
Published: Oct. 1, 2024
The
resident
microbiota
are
a
key
component
of
healthy
organism.
vast
majority
microbiome
studies
have
focused
on
bacterial
members,
which
constitute
significant
portion
microbial
biomass.
Recent
demonstrated
how
the
fungal
microbiota,
or
mycobiome,
influences
mammalian
biology
despite
its
low
abundance
compared
to
other
microbes.
Fungi
known
for
their
pathogenic
potential,
yet
fungi
also
prominent
colonizers
in
states,
highlighting
duality.
We
summarize
characteristics
that
define
gut
mycobiome
across
life,
factors
can
impact
composition,
and
identify
mechanisms
confer
health
benefits.
goal
this
review
is
synthesize
our
knowledge
regarding
composition
function
with
view
inspiring
future
therapeutic
advances.
Gut Microbes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Oct. 24, 2024
The
current
studies
have
shown
that
the
occurrence
and
development
of
chronic
obstructive
pulmonary
disease
(COPD)
are
closely
related
to
changes
in
gut
health
its
microenvironment,
even
some
diseases
significant
clinical
correlation
with
COPD.
dysbiosis
microbiota
observed
COPD
patients
also
suggests
a
potential
bidirectional
interaction
between
lung.
Communication
lung
may
occur
through
circulating
inflammatory
cells,
microbial
metabolites,
mediators,
but
mechanism
communication
is
still
under
study.
Therefore,
more
research
needed
this
area.
In
review,
we
summarize
recent
animal
models
on
role
gut-lung
axis
mechanisms,
so
as
provide
ideas
for
further
field.
addition,
summarized
negative
effects
medication
risk
factors
proposed
prevention
treatment
strategies.
Pathogens and Disease,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 9, 2025
Inflammatory
diseases
of
the
human
gastrointestinal
tract
are
affected
by
microbes
that
reside
in
mucosal
surfaces.
Patients
with
inflammatory
bowel
(IBD)
have
altered
bacterial
and
fungal
intestinal
compositions,
including
higher
levels
fecal
Candida
yeasts.
Ongoing
research
indicates
genetic
phenotypic
diversity
albicans
may
be
linked
disease
severity.
Here,
we
set
out
to
investigate
feces-derived
C.
strains
from
individuals
IBD
healthy
volunteers
through
microsatellite-based
genotyping
assays.
A
seven-locus
microsatellite
panel
was
applied,
which
six
loci
were
newly
developed.
It
appears
there
is
no
specific
lineage
associated
IBD,
but
rather
three
study
populations
(Crohn's
disease,
ulcerative
colitis,
volunteers)
do
distinguishable
distributions
genotypes.
In
addition,
characterization
means
enzyme
release
assays
revealed
trends
between
genotypes,
virulence-related
activity
clinical
biomarkers.
We
thus
show
typing
can
describe
strains,
these
indeed
correlate
genotype
or
disease.
This
opens
further
possibilities
fungi
relation
severity
inflammation
other
(intestinal)
diseases.